Novartis heart failure medicine Entresto™ substantially cuts 30-day hospital readmissions, new post-hoc analysis shows

Novartis heart failure medicine Entresto™ substantially cuts 30-day hospital readmissions, new post-hoc analysis shows

Nov 10, 2015

Source URL: https://qa1.novartis.us/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows-0

List of links present in page
  1. https://qa1.novartis.us/news/media-releases/novartis-heart-failure-medicine-entrestotm-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows-0